http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008542296-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
filingDate 2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008542296-A
titleOfInvention Treatment of eye disorders with sirtuin activators
abstract Sirtuin modulators, particularly sirtuin activators, are useful for the treatment of visual impairment. In general, sirtuin modulators inhibit the progression of visual dysfunction caused by various eye disorders. The present invention also includes pharmaceutically acceptable formulations of sirtuin modulators, particularly ophthalmically acceptable formulations. The present invention discloses compositions and methods for treating eye disorders that result in visual impairment or blindness (blindness). Specifically, the present invention discloses a method for treating visual dysfunction due to retinal or optic nerve damage.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018052019-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927046-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019534335-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014101313-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012516834-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020262497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018030389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7090336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018052019-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898738-B2
priorityDate 2005-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03062406-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003252760-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005034960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008501343-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005002672-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008527002-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466357197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467096371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466175998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468303042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7004

Total number of triples: 44.